PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-one | 267-135-7 | 67801-15-4 | - | - | - | - | 1 | - | - | - | - | Details |
3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-3-en-2-one | 265-450-4 | 65113-95-3 | - | - | - | - | 1 | - | - | - | - | Details |
3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one | 204-846-3 | 127-51-5 | - | - | 2 | - | 1 | - | - | - | - | Details |
3-methyl-2-pent-2-enylcyclopent-2-enone | 207-668-4 | 488-10-8 | - | - | - | - | 1 | - | - | - | - | Details |
3-methyl-2-butenyl salicylate | 271-434-8 | 68555-58-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
3-methyl-1-vinyl-1H-imidazolium methyl sulphate | 247-832-2 | 26591-72-0 | - | - | 1 | - | 1 | - | - | - | - | Details |
3-methyl-1-phenethylbutylamine | 229-007-9 | 6396-93-6 | - | - | - | - | 1 | - | - | - | - | Details |
3-methyl-1,5-pentanediyl diacrylate | 264-727-7 | 64194-22-5 | 1 | - | 2 | - | 1 | - | - | - | - | Details |
3-methyl-1,3-butandiol
MBD
|
459-270-7 | - | - | - | 1 | - | - | - | - | - | - | Details |
3-methoxypropylamine | 226-241-3 | 5332-73-0 | - | - | 2 | - | - | - | - | - | - | Details |